Showing 1–24 of 713 results
Molecule : SildenafilManufacturer : Aglowmed Pharmaceuticals Limited
Molecule : SildenafilManufacturer : Aglowmed Pharmaceuticals Limited
Molecule : SildenafilManufacturer : Khandelwal Laboratories Limited
Molecule : Abiraterone AcetateManufacturer : Aprazer Healthcare
Molecule : AcalabrutinibManufacturer : Ziska Pharmaceuticals Ltd
Molecule : Brentuximab VedotinManufacturer : Takeda Pharmaceuticals
Related Posts:
Ruxolitinib Tablets Receive FDA Approval for Hematologic Malignancies
The U.S. Food and Drug Administration (FDA) has approved Ruxolitinib tablets for the treatment of certain hematologic malignancies, marking another
READ MORE »May 18, 2026
Tovorafenib Approved in Europe for Children with BRAF-Altered Low-Grade Glioma
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 14, 2026.n n This marks an important
READ MORE »May 14, 2026
FDA Fast-Tracks Plixorafenib for BRAF V600E–Mutated Brain Tumors
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 14, 2026.n n Brain tumors, especially high-grade
READ MORE »April 14, 2026